- |||||||||| esmolol / Generic mfg.
Enrollment closed, Trial primary completion date: Postoperative Analgesia Impact of Narcotic Free Anesthesia (clinicaltrials.gov) - May 29, 2015 P=N/A, N=84, Active, not recruiting, Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2014 --> Jan 2013
- |||||||||| Trial completion: Web-based CBT for Children With Chronic Pain (clinicaltrials.gov) - May 28, 2015
P2, N=48, Completed, Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2014 --> May 2015 Active, not recruiting --> Completed
- |||||||||| Sancuso (granisetron) / Cumberland
Trial completion, Enrollment change, Trial primary completion date: Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer (clinicaltrials.gov) - May 28, 2015 P=N/A, N=4, Completed, Recruiting --> Completed Suspended --> Completed | N=60 --> 4 | Trial primary completion date: Jan 2012 --> Mar 2013
- |||||||||| Enrollment closed, Trial primary completion date: PIM: Pediatric Integrative Medicine Trial Pilot (clinicaltrials.gov) - May 27, 2015
P3, N=200, Active, not recruiting, Suspended --> Completed | N=60 --> 4 | Trial primary completion date: Jan 2012 --> Mar 2013 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Sep 2015
- |||||||||| Linzess (linaclotide) / Astellas, Ironwood Pharma, AbbVie
Trial completion, Enrollment change: A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C) (clinicaltrials.gov) - May 27, 2015 P3, N=1722, Completed, Recruiting --> Completed Active, not recruiting --> Completed | N=800 --> 1722
- |||||||||| Movicol (polyethylene glycol/sodium bicarbonate/sodium chloride/potassium chloride) / Mochida, Eisai, Norgine
Enrollment closed, Trial primary completion date: Maintenance Treatment for Children With Constipation (clinicaltrials.gov) - May 26, 2015 P=N/A, N=125, Active, not recruiting, Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2015 --> Apr 2015
- |||||||||| dexamethasone / Generic mfg., ondansetron / Generic mfg.
Trial completion, Trial primary completion date, Surgery, Bariatric surgery: Dexamethasone and Ondansetron Versus Placebo for Postoperative Nausea and Vomiting (clinicaltrials.gov) - May 26, 2015 P4, N=122, Completed, Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2015 --> Apr 2015 Recruiting --> Completed | Trial primary completion date: Dec 2015 --> Jan 2014
- |||||||||| Relistor (methylnaltrexone bromide) / Ono Pharma, Bausch Health
Trial completion: Methylnaltrexone Use for Opioid-induced Postoperative Constipation (clinicaltrials.gov) - May 19, 2015 P4, N=60, Completed, Active, not recruiting --> Completed | Trial primary completion date: Aug 2011 --> Feb 2011 Recruiting --> Completed
- |||||||||| armodafinil / Generic mfg.
Trial completion: Armodafinil in Binge Eating Disorder (BED) (clinicaltrials.gov) - May 14, 2015 P3, N=60, Completed, Recruiting --> Completed Active, not recruiting --> Completed
- |||||||||| Trial completion: Invaplex 50 Vaccine Dose-Ranging (clinicaltrials.gov) - Apr 28, 2015
P1, N=32, Completed, Active, not recruiting --> Completed No longer recruiting --> Completed
- |||||||||| Enrollment closed, MRI: MRI and Microbiota Analysis in Constipation (clinicaltrials.gov) - Apr 25, 2015
P=N/A, N=24, Active, not recruiting, No longer recruiting --> Completed Recruiting --> Active, not recruiting
- |||||||||| Sustol (granisetron ER) / Heron Therapeutics
Enrollment closed, Trial primary completion date: A Prospective, Multicenter, Study of APF530 (Granisetron) SC for Prevention of CINV in Patients Receiving HEC (clinicaltrials.gov) - Apr 23, 2015 P3, N=1000, Active, not recruiting, Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2014 --> May 2015
- |||||||||| Trial completion, Enrollment change, Trial primary completion date: The Effect of Oxytocin on Gastric Emptying (clinicaltrials.gov) - Apr 7, 2015
P=N/A, N=14, Completed, Recruiting --> Completed Recruiting --> Completed | N=30 --> 14 | Trial primary completion date: Oct 2010 --> Apr 2015
- |||||||||| Relistor (methylnaltrexone bromide) / Ono Pharma, Bausch Health
Enrollment change, Trial termination, Trial primary completion date: Can Methylnaltrexone Safely Treat Opioid Related Constipation in the Emergency Department? (clinicaltrials.gov) - Apr 3, 2015 P4, N=11, Terminated, Recruiting --> Completed | N=30 --> 14 | Trial primary completion date: Oct 2010 --> Apr 2015 N=60 --> 11 | Withdrawn --> Terminated | Trial primary completion date: Nov 2010 --> Dec 2011; Unable to recruit enough patients at a single center.
|